Editorial
Sensitization of tumor cells by targeting histone deacetylases
Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs
The role of glutathione in brain tumor drug resistance
Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics
Nuclear export of proteins and drug resistance in cancer
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones
Acquired resistance to drugs targeting receptor tyrosine kinases
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53☆
Regulation of chemoresistance via alternative messenger RNA splicing
ABC transporters and their role in nucleoside and nucleotide drug resistance
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters